Candidozyma auris (Candida auris): responding to an emerging threat to public health, updated guidance for acute healthcare settings
Candidozyma auris (formerly Candida auris) is a rapidly emerging fungal pathogen with a global distribution. The World Health Organization has categorised C. auris as a critical priority fungal pathogen. C. auris can result in invasive infection, colonisation and outbreaks in healthcare settings; management may be complicated by resistance to antifungal agents. In recent years, C. auris has been increasingly detected and associated with significant hospital outbreaks in England. The UK Health Security Agency (UKHSA) is working with NHS England and other partners to mitigate risks to patients and the public and will imminently publish updated guidance for acute healthcare settings.
Join us for a webinar organised jointly by HIS and UKHSA to hear from colleagues in UKHSA and NHS England including subject matter experts, as they provide an overview of: C. auris emergence in the UK, introduce new guidance for acute healthcare settings, and outline the current approach to risk mitigation.
Submit a question to our panel by 9am on Thur 27 March via the link below: